Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
6Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
Valneva SE (VALN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
13Total relationships
2Distinct source URLs
3High confidence
0.738Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Valneva SE Suppliers
Ticker
Name
Confidence
Evidence
LIMMATECH-BIOLOGICS
LIMMATECH-BIOLOGICS
90%
We have in-licensing agreements relating to certain of our products and product candidates, including with LimmaTech Biologics for S4V2 (Shigella).
Reciprocal relationship from KMDA graph: Reciprocal relationship from VALN graph: Reciprocal relationship from KMDA graph: Reciprocal relationship from VALN graph: Reciprocal relationship from KMDA g…
NBTX
Nanobiotix S.A.
72%
Reciprocal relationship from NBTX graph: NY (State University of New York), Buffalo, USA. Mr. Bart Van Rhijn brings extensive experience in consultancy, technology, and life sciences industries and j…
SNYNF
Sanofi
72%
en and Kaketsuken (Japan), both with inactivated vero-cell based vaccines, Chengdu (China and GAVI/UNICEF markets) with a live-attenuated vaccine, and Sanofi’s live-attenuated chimeric vaccine, IMOJE…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from VALN graph: en and Kaketsuken (Japan), both with inactivated vero-cell based vaccines, Chengdu (China and GAVI/UNICEF markets) w…
Reciprocal relationship from KMDA graph: Reciprocal relationship from VALN graph: Reciprocal relationship from KMDA graph: .G., Kedrion, Chiesi Farmaceutici S.p.A, BPL and Valneva SE, which are sold …
SNYNF
Sanofi
72%
ly traded French company that develops a treatment against peanut allergy. Ms. Ferrère served on the board of directors of Innate Pharma SA., a French global oncology-focused biotech company, from 20…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from VALN graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from VALN graph: Reciprocal relationship from SNYN…
Reciprocal relationship from CRS graph: Reciprocal relationship from VALN graph: Reciprocal relationship from CRS graph: Reciprocal relationship from VALN graph: Reciprocal relationship from CRS grap…
CRUCELL-SWEDEN-AB-BERLIN-CHEMIE-AG
CRUCELL-SWEDEN-AB-BERLIN-CHEMIE-AG
62%
tates, Canada, the United Kingdom, Sweden, France, Austria, Norway, Denmark, Finland, Belgium, and the Netherlands. We commercialize our own and third-party vaccine brands to both private and governm…
INTERCELL-AG
INTERCELL-AG
62%
materials for which we rely on a single supplier could adversely affect our ability to manufacture our products and significantly raise our cost of production. We have not qualified secondary sources…
Valneva SE Debt Obligations
Instrument
Description
Confidence
Evidence
VALN-DEBT
Debt stack $244.3M
90%
Market cache reports total debt of $244.3M.
Valneva SE Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Valneva SE.
Valneva SE Ownership
Holder
Name
Confidence
Evidence
VALN-OWNER-FRAZIER-LIFE-SCIENCES-MANAGEMENT
Frazier Life Sciences Management, L.P.
90%
13F overlay lists Frazier Life Sciences Management, L.P. as top holder; 23 tracked holders.
